Coffee, caffeine and non-alcoholic fatty liver disease?
Main Authors: | Oliver John Kennedy, Paul Roderick, Robin Poole, Julie Parkes |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-05-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/1756283X16636765 |
Similar Items
-
Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney disease
by: Paul Roderick, et al.
Published: (2020-09-01) -
All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study
by: Oliver J. Kennedy, et al.
Published: (2021-06-01) -
Misclassification of coffee consumption data and the development of a standardised coffee unit measure
by: Paul Roderick, et al.
Published: (2020-10-01) -
Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease
by: Bilon Khambu, et al.
Published: (2018-09-01) -
Effects of a Low Dose of Caffeine Alone or as Part of a Green Coffee Extract, in a Rat Dietary Model of Lean Non-Alcoholic Fatty Liver Disease without Inflammation
by: Ana Magdalena Velázquez, et al.
Published: (2020-10-01)